0001214659-20-000573.txt : 20200124
0001214659-20-000573.hdr.sgml : 20200124
20200124163017
ACCESSION NUMBER: 0001214659-20-000573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200122
FILED AS OF DATE: 20200124
DATE AS OF CHANGE: 20200124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BARLIANT RONALD
CENTRAL INDEX KEY: 0001288093
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 20545861
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANIGEN, INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20040609
4
1
marketforms-47551.xml
PRIMARY DOCUMENT
X0306
4
2020-01-22
0001293310
HUMANIGEN, INC
HGEN
0001288093
BARLIANT RONALD
C/O HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400
BURLINGAME
CA
94010
true
false
false
false
Stock Option (Right to Buy)
0.38
2020-01-22
4
A
false
50000
0.38
A
2020-01-22
2030-01-21
Common Stock
50000
50000
D
The stock option was granted in lieu of the $13,500 cash compensation payable to Mr. Barliant in respect of his services as a director during the fourth quarter of 2019.
/s/ Cameron Durrant, Attorney-in-Fact
2020-01-24